Skip to main content
Premium Trial:

Request an Annual Quote

Ontario Institute Launches Genomics Sector Innovation Network

NEW YORK (GenomeWeb News) – The non-profit Ontario Genomics Institute and the Ontario Ministry of Research and Innovation have launched a new initiative called the Genomics Sector Innovation Network that aims to link various stakeholders in Ontario's genomics sector.
 
The network is on online portal that will contain searchable information about large-scale genomic and proteomic projects as well as participating researchers and institutions. It is intended to be a knowledge and communication base for those in working in genomics on the academic research, industry, and investment fronts in Ontario and the rest of Canada, OGI said today.
 
The site also includes resources for those interested in genomics-related employment opportunities, technology transfer, and news.
 
“Ontario is a global leader in genomics and proteomics research and a hotbed of research and commercialization activities thanks to our thriving life sciences community,” John Wilkinson, Ontario’s minister of research and innovation, said in a statement. “Investing in world-class research and innovation is part of our government’s plan to improve our quality of life, boost Ontario’s global economic competitiveness, and spark the next generation of highly skilled, good-paying jobs for Ontario families.”
 
The Genomics Sector Innovation Network portal is available here.

The Scan

Push Toward Approval

The Wall Street Journal reports the US Food and Drug Administration is under pressure to grant full approval to SARS-CoV-2 vaccines.

Deer Exposure

About 40 percent of deer in a handful of US states carry antibodies to SARS-CoV-2, according to Nature News.

Millions But Not Enough

NPR reports the US is set to send 110 million SARS-CoV-2 vaccine doses abroad, but that billions are needed.

PNAS Papers on CRISPR-Edited Cancer Models, Multiple Sclerosis Neuroinflammation, Parasitic Wasps

In PNAS this week: gene-editing approach for developing cancer models, role of extracellular proteins in multiple sclerosis, and more.